Maria Lahtinen appointed as a Quality Director

Maria Lahtinen has been appointed to the role of Quality Director since 1st Jan 2023 to support the company growth and transfer from preclinical to clinical stage.

Maria has a long pharma experience in various drug development activities from laboratory to clinics in companies of various sizes. At Sartar her main responsiblity is to develop the company quality system to support all drug development activities. With strong laboratory background Maria will also be involved in analytical and CMC activities.

“It is great to get this possiblity to utilize all expertise and experience collected during my past career. The phase of the company is very interesting and I am pleased to work with the experienced Sartar team to be able to develop solutions for patients with high unmet medical needs.”